Skip to main content
OpenTrials
Completed

NCT Number: NCT01862276

Role of Bile Duct Resection in Major Hepatectomy Due to Intrahepatic Cholangiocarcinoma

To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Osaka University, Graduate School of Medicine

Osaka, 565-0871, Japan

About this study

The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cases of major hepatectomy due to intrahepatic cholangiocarcinoma

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. 3-year recurrence-free survival rate

    Time frame: 11 years (2000-2010)

  2. Ratio of local recurrence at the hepatico-duodenal ligament

    Time frame: 11 years

Sponsors and collaborators

Lead sponsor

Kansai Hepatobiliary Oncology Group

Network

Registry information

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
May 24, 2013
Registry last updated
Jul 1, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.